HOTH
Price:
$1.07
Market Cap:
$24.11M
Rocket One, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in Hoboken, NJ.
Industry
Biotechnology
IPO Date
2019-02-15
Stock Exchange
NASDAQ
Ticker
HOTH
According to Hoth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.39. This represents a change of -69.49% compared to the average of 11.11 of the last 4 quarters.
The mean historical Current Ratio of Hoth Therapeutics, Inc. over the last ten years is 10.39. The current 3.39 Current Ratio has changed 3.16% with respect to the historical average. Over the past ten years (40 quarters), HOTH's Current Ratio was at its highest in in the September 2019 quarter at 163.29. The Current Ratio was at its lowest in in the June 2017 quarter at 0.
Average
10.39
Median
9.20
Minimum
1.44
Maximum
24.87
Discovering the peaks and valleys of Hoth Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 316.47%
Maximum Annual Current Ratio = 24.87
Minimum Annual Increase = -94.22%
Minimum Annual Current Ratio = 1.44
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 4.72 | -48.64% |
| 2024 | 9.20 | -38.51% |
| 2023 | 14.96 | 208.57% |
| 2022 | 4.85 | -60.23% |
| 2021 | 12.19 | -20.47% |
| 2020 | 15.32 | 155.91% |
| 2019 | 5.99 | 316.47% |
| 2018 | 1.44 | -94.22% |
The current Current Ratio of Hoth Therapeutics, Inc. (HOTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.63
5-year avg
9.18
10-year avg
10.39
Hoth Therapeutics, Inc.’s Current Ratio is greater than Curis, Inc. (1.00), less than BriaCell Therapeutics Corp. (7.07), less than Palisade Bio, Inc. (23.71), greater than Processa Pharmaceuticals, Inc. (0.98), greater than Aspire Biopharma Holdings, Inc. (2.26), less than Lexaria Bioscience Corp. (26.88), greater than FibroBiologics, Inc. Common Stock (1.59), less than Pulmatrix, Inc. (4.96), greater than Daré Bioscience, Inc. (1.03), greater than Entero Therapeutics, Inc. (0.16),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.00 | $5.54M | |
| 7.07 | $5.46M | |
| 23.71 | $324.59M | |
| 0.98 | $4.80M | |
| 2.26 | $759.15K | |
| 26.88 | $11.04M | |
| 1.59 | $1.61M | |
| 4.96 | $5.33M | |
| 1.03 | $20.66M | |
| 0.16 | $13.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hoth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hoth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Hoth Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Hoth Therapeutics, Inc. (HOTH)?
What is the highest Current Ratio for Hoth Therapeutics, Inc. (HOTH)?
What is the 3-year average Current Ratio for Hoth Therapeutics, Inc. (HOTH)?
What is the 5-year average Current Ratio for Hoth Therapeutics, Inc. (HOTH)?
How does the current Current Ratio for Hoth Therapeutics, Inc. (HOTH) compare to its historical average?